
Co-Diagnostics CODX
$ 4.4
101.83%
Quarterly report 2025-Q3
added 11-13-2025
Co-Diagnostics EV/EBITDA Ratio 2011-2026 | CODX
Annual EV/EBITDA Ratio Co-Diagnostics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.62 | 7.59 | -7.61 | -4.77 | -6.33 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.59 | -7.61 | -1.5 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.13 | - | $ 4.89 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 75.5 | -0.31 % | $ 5.1 B | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 455.28 | -0.36 % | $ 13.1 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 229.6 | -0.87 % | $ 25.3 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 156.54 | -0.92 % | $ 7.76 B | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 165.42 | -0.95 % | $ 28.4 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.6 | -1.29 % | $ 426 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.25 | -14.38 % | $ 6.81 M | ||
|
National Research Corporation
NRC
|
21 | $ 17.47 | -0.26 % | $ 391 M | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 569.86 | -1.5 % | $ 45.8 B | ||
|
Illumina
ILMN
|
70.5 | $ 122.99 | -0.65 % | $ 19.6 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 100.22 | -0.13 % | $ 8.27 B | ||
|
Guardant Health
GH
|
-28.8 | $ 84.35 | -0.65 % | $ 10.6 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.38 | -1.08 % | $ 414 M | ||
|
Celcuity
CELC
|
-2.38 | $ 103.02 | -3.49 % | $ 4.06 B | ||
|
Precipio
PRPO
|
-1.8 | $ 26.93 | - | $ 35 M | ||
|
Personalis
PSNL
|
-7.07 | $ 7.71 | 1.37 % | $ 457 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 263.52 | -0.36 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
RadNet
RDNT
|
17.6 | $ 60.39 | -2.19 % | $ 4.54 B | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 3.41 | -2.16 % | $ 1.83 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 7.91 | -2.35 % | $ 1.01 B | ||
|
Agilent Technologies
A
|
27.4 | $ 111.72 | -0.27 % | $ 34 B | ||
|
Natera
NTRA
|
-19.5 | $ 194.13 | -2.98 % | $ 19.1 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.24 | -1.82 % | $ 919 M | ||
|
OPKO Health
OPK
|
25.9 | $ 1.14 | -0.88 % | $ 791 M | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.58 | -0.68 % | $ 275 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 25.84 | 0.35 % | $ 718 M | ||
|
Sotera Health Company
SHC
|
24.8 | $ 13.77 | -0.79 % | $ 3.91 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 194.57 | -0.54 % | $ 21.6 B | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 7.37 | -1.73 % | $ 29.4 M |